DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...
Hosted on MSN1d
Evercore ISI Group Downgrades DENTSPLY SIRONA (XRAY)Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...
DENTSPLY SIRONA (XRAY – Research Report) received a Hold rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...
Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, ...
Evercore ISI downgraded Dentsply Sirona (XRAY) to In Line from Outperform with a $20 price target The firm is moving to the sidelines as it ...
Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...
The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to ...
Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.
NDAQ:XRAY) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Dentsply Sirona Inc. (XRAY) Shareholders ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive ...
Prior to the start of the Class Period, on December 21, 2020, Dentsply paid $1.04 billion in cash to acquire Byte, a manufacturer of affordable, “doctor-directed,” direct-to-consumer (“DTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback